Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17701
Country/Region: South Sudan
Year: 2014
Main Partner: Columbia University
Main Partner Program: International Center for AIDS Care and Treatment Programs
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $1,800,000 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

ICAP will provide focused support to the national adult and pediatric HIV treatment program which includes the military health care service delivery sites through:

1) Targeted technical assistance to improve the quality of services delivered, in particular to support patient adherence and retention to minimize disruptions among those on ART. This will enhance the impact of the limited funding available for treatment, as well as minimize the chance for transmission of drug-resistant virus.

2) Strengthening pre-ART services and monitoring and tracking systems to keep this population engaged in care and ready to start ART when resources become available.

3) Focusing this support in high-impact geographic areas and populations at greatest risk, such as the states of Western (WE) and Central Equatoria (CE)

ICAP will provide ongoing mentoring and supportive supervision for improved service delivery at selected ART sites in high prevalence areas with specific emphasis on improved retention and adherence. Additional strategies to promote retention of both ART and pre-ART patients will be pursued including decentralization of care by training additional healthcare workers and counselors in the provision of preventive care package (cotrimoxazole, TB screening, condoms, prevention education) for individuals in pre-ART as well as access to every six month CD4 testing, and consideration for decentralized care for those on ART.

ICAP will provide ongoing training of clinical officers, nurses and other health care workers at the selected ART sites. The training will cover HTC including PITC, clinical and laboratory monitoring of ART patients, OIs and STIs screening and management, national ART treatment guidelines with the emphasis on appropriate use of ARVs, and how to design a

Mechanism Allocation by Budget Code for Selected Year
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $500,000
Treatment: Adult Treatment (HTXS) $1,100,000
Treatment: Pediatric Treatment (PDTX) $200,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D_NGI By Age: <15 2015 2,430
C2.1.D_NGI By Age: 15+ 2015 24,570
C2.1.D_NGI By Age/Sex: <15 Female 2015 1,775
C2.1.D_NGI By Age/Sex: <15 Male 2015 655
C2.1.D_NGI By Age/Sex: 15+ Female 2015 17,199
C2.1.D_NGI By Age/Sex: 15+ Male 2015 7,371
C2.1.D_NGI By Sex: Female 2015 18,900
C2.1.D_NGI By Sex: Male 2015 8,100
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 27,000
C2.1.D_NGI Sum of Age disaggregates 2015 27,000
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 27,000
C2.1.D_NGI Sum of Sex disaggregates 2015 27,000
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,332
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 490
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 12,900
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 5,528
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 20,250
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 20,250
CARE_NEW Aggregated Age/sex: <15 Female 2015 592
CARE_NEW Aggregated Age/sex: <15 Male 2015 218
CARE_NEW Aggregated Age/sex: 15+ Female 2015 5,733
CARE_NEW Aggregated Age/sex: 15+ Male 2015 2,457
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 9,000
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 9,000
CARE_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 22
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 22
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 22
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 22
LAB_CAP By Point-of-care testing sites 2015 22
LAB_CAP By site support type: Technical Assistance-only (TA) 2015 22
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 22
LAB_CAP Sum of Site Support Type disaggregates 2015 22
QI_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 15
QI_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 22
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 15
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 15
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 22
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 22
SITE_SUPP By program area/support type: Care and Support Technical Assistance-only (TA) 2015 22
SITE_SUPP By program area/support type: HTC Technical Assistance-only (TA) 2015 22
SITE_SUPP By program area/support type: Lab Technical Assistance-only (TA) 2015 22
SITE_SUPP Number of unique sites supported by PEPFAR 2015 22
TX_CURR Aggregated Age/Sex: <1 Female 2015 36
TX_CURR Aggregated Age/Sex: <1 Male 2015 36
TX_CURR Aggregated Age/Sex: <15 Female 2015 784
TX_CURR Aggregated Age/Sex: <15 Male 2015 290
TX_CURR Aggregated Age/Sex: 15+ Female 2015 7,598
TX_CURR Aggregated Age/Sex: 15+ Male 2015 3,256
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 12,000
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,074
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 10,854
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 11,928
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 36
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 36
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 784
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 290
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 7,598
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 3,256
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 12,000
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 1,074
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 10,854
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 11,928
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 4,400
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 11,000
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 16,000
TX_SITE By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 22
TX_SITE By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites 2015 22
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 22
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 22
TX_SITE Total number of PEPFAR-supported ART sites 2015 22
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 22